Obsessive Compulsive Treatment Efficacy Trial (OCTET)

ISRCTN ISRCTN73535163
DOI https://doi.org/10.1186/ISRCTN73535163
Secondary identifying numbers HTA 09/81/01
Submission date
05/04/2011
Registration date
05/04/2011
Last edited
24/01/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Obsessive compulsive disorder (OCD) is a common problem which affects many people and rarely improves without help. Experts recommend that people with OCD receive a 'talking treatment' called cognitive behavioural therapy (CBT). However, waiting lists for this treatment can be very long. Experts also suggest that some patients might benefit from CBT provided as 'self-help' through a book or computer, with assistance from a mental health professional. The aim of this study is to find out whether the new treatments (computerised CBT and guided self-help) work well for people with OCD, and if people like the treatments.

Who can participate?
Adults aged 18 and above with OCD on a waiting list for therapist-led CBT

What does the study involve?
Two different self-help treatments for OCD are tested by comparing them with patients on a waiting list for scheduled individual CBT. People who are happy to take part are asked a series of questions relating to their health. They are then randomly allocated to one of the following three treatments:
1. Computerised CBT using an online computer system called OCFighter, with help from a mental health professional, usually by phone, but can be face-to-face
2. Guided self-help, using a book which helps people use CBT, with help from a mental health professional either face-to-face or by phone
3. Waiting list for scheduled individual CBT (the currently recommended treatment route for OCD)
Both self-help treatments are delivered over a 12-week period. Taking part in the study does not mean that participants cannot have individual CBT later. Participants can stay on the waiting list for CBT whatever happens in the study. Participants are asked a further set of questions to see how they are feeling at 3, 6 and 12 months after the start of the study. The study takes 4 years to complete, but participants are only involved for 12 months. Some participants are asked for permission to conduct a separate interview to discuss how they found their treatment, and whether it has helped them. Only about 1 in 10 participants are asked; participants can take part in the study without agreeing to this interview.

What are the possible benefits and risks of participating?
Computerised CBT and guided self-help are quite new treatments for OCD. At the moment it is not known how well they work. It may be that people do not find these treatments helpful. People can choose to stop using them at any point during the study without having to give a reason why. There are no known side effects of either treatment. Waiting list times for scheduled individual CBT vary from area to area. If the waiting list in a local area is less than 12 weeks people may have to wait slightly longer for their scheduled CBT appointment. People still have the opportunity to receive individual CBT after taking part in the study.

Where is the study run from?
University of Manchester (UK)

When is the study starting and how long is it expected to run for?
September 2011 to August 2015

Who is funding the study?
NIHR Health Technology Assessment Programme (UK)

Who is the main contact?
Prof. Karina Lovell
Karina.Lovell@manchester.ac.uk

Contact information

Prof Karina Lovell
Scientific

University of Manchester
School of Nursing, Midwifery & Social Work
Room 6.322A
Jean McFarlane Building
Oxford Road
Manchester
M13 9PL
United Kingdom

Phone +44 (0)161 306 7853
Email Karina.Lovell@manchester.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleObsessive Compulsive Treatment Efficacy Trial (OCTET)
Study acronymOCTET
Study hypothesis1. Identify and confirm estimated recruitment rates for an obsessive compulsive disorder (OCD) treatment trial via an internal pilot phase aimed at evaluating recruitment rates and primary outcome point
2. Proceed seamlessly to a full RCT (if recruitment is successful in the pilot phase) to determine:
2.1. The clinical and cost-effectiveness of two self-managed CBT interventions (cCBT and bibliotherapy) compared to a CBT waiting list in the management of OCD patients in the short term at 3- and 6-month follow-up
2.2. The clinical and cost-effectiveness of self-managed therapies plus conventional CBT compared to waiting list plus conventional CBT at 12-month follow-up
3. Determine patient compliance and patient and health professional acceptability of the two self-managed therapy packages (cCBT & GSH)
Ethics approval(s)NRES Committee North West - Lancaster; 24/05/2011, ref: 11/NW/0276
ConditionObsessive compulsive disorder
Intervention1. Computer-aided cognitive based therapy (cCBT) package (OC Fighter) over 12 weeks
2. Supported by six, 10-minute brief scheduled telephone calls, face to face or email contact (depending on patient preference) from a mental health professional (total direct clinical input 60 minutes)
3. Bibliotherapy (Guided Self-Help) will consist of a self-help book 'Overcoming OCD: a workbook' written by Karina Lovell
4. Participants will receive weekly guidance from a mental health professional for an initial session of 60 minutes (either face to face or telephone dependent on patient preference)
5. This is followed by up to 10 brief (30 minute) scheduled telephone, email or face to face (dependent on patient preference) sessions over a 12-week period (total direct clinical input: 6 hours).
6. Comparator - patients on a waiting list for CBT

Updated 17/09/2014: Recruitment is now complete.
Intervention typeOther
Primary outcome measureYale-Brown Obsessive Compulsive Scale (Y BOCS) checklist
Secondary outcome measures1. Self-reported health-related quality of life (SF-36)
2. Self-reported OCD symptoms (YBOCs self-rated)
3. Generic mental health (CORE-OM)
4. Depression (PHQ9)
5. Anxiety (GAD-7)
6. Functioning (WSA)
7. Health-related quality of life (EQ5D)
8. Employment status (IAPT Employment Status questions A13 –A15)
9. Patient satisfaction (CSQ) and acceptability (qualitative interviews)
10. Percentage of patients not improved or partially improved requiring more intensive CBT

Added 17/09/2014:
11. Adult Service Use Schedule (AD-SUS) – self complete and interview
Overall study start date01/09/2011
Overall study end date31/08/2015

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants432
Total final enrolment475
Participant inclusion criteriaCurrent inclusion criteria as of 17/09/2014:
1. Adults aged 18 and above meeting Diagnostic and Statistical Manual of Mental Disorders (DSM) IV criteria for obsessive compulsive disorder (assessed using six OCD questions from the Mini-International Neuropsychiatric Interview [M.I.N.I.])
2. Scoring 16 or over on the Yale Brown Obsessive Compulsive Checklist (YBOCS)
3. On a waiting list for therapist-led cognitive behavioral therapy (CBT) in either primary or secondary mental health care settings
4. Able to read English at a level of 11 years and above

Previous inclusion criteria:
1. Adults aged 18 and above meeting Diagnostic and Statistical Manual of Mental Disorders (DSM) IV criteria for obsessive compulsive disorder (assessed using the Structured Clinical Interview for DSM-IV [SCID-IV])
2. Scoring 16 or over on the Yale Brown Obsessive Compulsive Checklist (YBOCS)
3. On a waiting list for therapist-led cognitive behavioral therapy (CBT) in either primary or secondary mental health care settings
4. Able to read English at a level of 11 years and above
Participant exclusion criteriaCurrent exclusion criteria as of 17/09/2014:
1. Participants who are actively suicidal
2. Patients with organic brain disease
3. Those who are experiencing psychosis
4. Those who have a diagnosis (DSM IV) criteria of drug or alcohol misuse
5. Patients who are currently receiving a psychological treatment for OCD
6. Those who have literacy or language difficulties to an extent which would preclude them from reading written or web-based materials or conversing with a health professional


Previous exclusion criteria:
1. Participants who are actively suicidal
2. Patients with organic brain disease
3. Those who are experiencing psychosis
4. Those who have a diagnosis (DSM IV) criteria of drug or alcohol misuse
5. Patients who are currently receiving a psychological treatment for OCD
6. Patients who have received CBT for OCD in the last 6 months
7. Those who have literacy or language difficulties to an extent which would preclude them from reading written or web-based materials or conversing with a health professional
8. Patients who have been prescribed or changed to an alternative anti-depressant in the 12 weeks prior to assessment will be excluded. These patients will be offered a further assessment following 12 weeks of stable medication if there are no plans to increase the medication
Recruitment start date01/02/2012
Recruitment end date01/05/2014

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

University of Manchester
Manchester
M13 9PL
United Kingdom

Sponsor information

University of Manchester (UK)
University/education

Research & Development Office
c/o Nalin Thakker
2nd Floor
Christie Building
University of Manchester
Manchester
M13 9PL
England
United Kingdom

ROR logo "ROR" https://ror.org/027m9bs27

Funders

Funder type

Research organisation

Health Technology Assessment Programme
Government organisation / National government
Alternative name(s)
NIHR Health Technology Assessment Programme, HTA
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing planNot provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 10/07/2014 Yes No
Results article results 27/06/2017 Yes No
Results article Clinical effectiveness, cost-effectiveness and acceptability 01/06/2017 24/01/2023 Yes No

Editorial Notes

24/01/2023: The following changes have been made:
1. Publication reference added.
2. The final enrolment number has been added from the reference.
28/06/2017: Publication reference added.